Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter

FDA classification

FDA Class 2 ·Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter

Sensor, Pressure, Aneurysm, Implantable

FDA classification

FDA Class 2 ·Sensor, Pressure, Aneurysm, Implantable

Pipette, Sahli

FDA classification

FDA Class 1 ·Pipette, Sahli

Rongeur, Lachrymal Sac

FDA classification

FDA Class 1 ·Rongeur, Lachrymal Sac

Tunneled Catheter Remover

FDA classification

FDA Class 2 ·Tunneled Catheter Remover

Gamma Globulin, Fitc, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Gamma Globulin, Fitc, Antigen, Antiserum, Control

Nebulizer (Direct Patient Interface)

FDA classification

FDA Class 2 ·Nebulizer (Direct Patient Interface)

Stent, Coronary

FDA classification

FDA Class 3 ·Stent, Coronary

Sars-Cov-2 Serology Test

FDA classification

FDA Class 2 ·Sars-Cov-2 Serology Test

Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19

FDA classification

FDA Not Classified ·Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19

Non-Sars Coronavirus Multiplex Nucleic Acid Assay

FDA classification

FDA Class 2 ·Non-Sars Coronavirus Multiplex Nucleic Acid Assay

Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

FDA classification

FDA Class 2 ·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis

FDA classification

FDA Not Classified ·Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis

Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

FDA classification

FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

FDA classification

FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

FDA classification

FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

FDA classification

FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings